Galderma Group AG (SWX:GALD)

Switzerland flag Switzerland · Delayed Price · Currency is CHF
98.25
+0.25 (0.26%)
May 14, 2025, 2:44 PM CET
40.06%
Market Cap 23.27B
Revenue (ttm) 4.02B
Net Income (ttm) 209.33M
Shares Out 237.41M
EPS (ttm) 0.88
PE Ratio 111.49
Forward PE 39.31
Dividend 0.15 (0.15%)
Ex-Dividend Date Apr 25, 2025
Volume 57,703
Average Volume 375,245
Open 97.95
Previous Close 98.00
Day's Range 96.80 - 98.70
52-Week Range 64.75 - 119.60
Beta n/a
RSI 59.48
Earnings Date Jul 24, 2025

About Galderma Group AG

Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services that span the spectrum of the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Dysport/Azzalure, Alluzience, Restylane, and Sculptra in injectable aesthetics; Cetaphil and Alastin in dermatological skincare; and Soolantra, Epiduo, Differin, Aklief, Epsolay, Twyneo, Oracea, Metvix, Benzac, and Loceryl in therapeutic ... [Read more]

Sector Healthcare
Founded 1981
Employees 6,545
Stock Exchange SIX Swiss Exchange
Ticker Symbol GALD
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.